News
Hosted on MSN2mon
Hologic pockets CE mark for contrast biopsy softwareHologic has obtained a CE mark in Europe for Affirm, its contrast biopsy software for use in contrast-enhanced mammography (CEM). Affirm facilitates the targeting and acquisition of tissue samples ...
1mon
Zacks.com on MSNHologic Wins Key Approvals Post Q1 Results: Buy or Hold HOLX Stock?Last week, Hologic HOLX earned two key regulatory approvals. The company’s Affirm Contrast Biopsy software has earned the CE ...
The hospital purchased a Hologic Affirm Breast Biopsy Guidance System recently for $500,000, according to President and CEO Kelli Powers, and since then, they have performed multiple mammograms ...
February 2024: Hologic rolled out its Selenia Dimensions 3D Mammography System for better detection of breast cancer, employing advanced biopsy technology to ensure that the tissue is sampled in ...
Thermo Fisher Scientific, Hologic, Roche, and Illumina – key innovators in biopsy tools and genomic profiling US, NY, UNITED STATES, April 9, 2025 /EINPresswire / -- Global Cancer Biopsy Market ...
And because awareness will keep increasing, these new innovative biopsy solutions are sure to attract greater demand with more precise diagnoses and improved outcomes in the treatment of breast cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results